Related Experiment Video
Updated: Jul 23, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Link between fibrosis-specific biomarkers and interstitial fibrosis in hypertrophic cardiomyopathy
Aleksandra Karabinowska-Małocha1,2, Ewa Dziewięcka3, Magdalena Szymańska4
1Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, John Paul II Hospital, Kraków, Poland. akarabinowska@gmail.com.
Insights
Galectin-3 levels predict interstitial fibrosis in hypertrophic cardiomyopathy (HCM) patients, as measured by extracellular volume (ECV) via cardiac magnetic resonance. Other fibrosis biomarkers were not useful, but cardiac biomarkers showed a positive correlation with fibrosis.
Area of Science:
- Cardiology
- Biomarker Research
- Medical Imaging
Background:
- Cardiac fibrosis, particularly interstitial fibrosis, is a significant factor in hypertrophic cardiomyopathy (HCM) with clinical implications.
- Interstitial fibrosis is less understood compared to replacement fibrosis in HCM.
- Understanding interstitial fibrosis is crucial for managing HCM progression.
Purpose of the Study:
- To investigate the association between serum biomarkers and interstitial fibrosis in HCM patients.
- To assess interstitial fibrosis using extracellular volume (ECV) measured by cardiac magnetic resonance (CMR).
- To identify potential biomarkers for predicting interstitial fibrosis in HCM.
Main Methods:
- 50 HCM patients underwent 3T CMR to quantify interstitial fibrosis via ECV.
- Serum levels of cardiac biomarkers (troponin T, NT-proBNP) and fibrosis biomarkers were measured.
- Patients were stratified based on median ECV values for comparative analysis.
Main Results:
- Galectin-3 and body mass index were identified as independent predictors of ECV.
- Serum galectin-3, troponin T, and NT-proBNP levels significantly correlated with ECV.
- Patients with higher ECV showed significant differences in NT-proBNP and galectin-3 levels.
Conclusions:
- Galectin-3 is a valuable independent predictor of interstitial fibrosis in HCM, indicated by elevated ECV.
- Standard fibrosis-specific biomarkers were not effective in detecting interstitial fibrosis in this HCM cohort.
- A positive correlation exists between traditional cardiac biomarkers and interstitial fibrosis in HCM patients.
Background:
Cardiac fibrosis is a hallmark of hypertrophic cardiomyopathy (HCM) and has confirmed unfavorable clinical significance. Replacement fibrosis is better known and has already been studied on a larger scale, whereas interstitial fibrosis is less explored.
Aims:
We aimed to analyze the relationship between serum biomarkers and interstitial fibrosis, as assessed with cardiac magnetic resonance (CMR) in HCM patients.
Methods:
We performed 3T CMR scans in 50 HCM patients to assess interstitial fibrosis as expressed by extracellular volume (ECV). In all patients, we determined levels of serum cardiac-specific (troponin T [TnT], N-terminal prohormone of brain natriuretic peptide [NT-proBNP]) and fibrosis-specific (procollagen I C-terminal propeptide, procollagen III N-terminal propeptide, transforming growth factor β1, galectin-3) biomarkers. Patients were divided based on their median value of ECV.
Results:
The final study population included 49 patients. The median value of ECV in our cohort was 28.1%. Patients stratified according to median ECV differed in terms of several variables: body mass index, late gadolinium extent, NT-proBNP, and galectin-3 levels (all P <0.05). Cardiac biomarkers (TnT and NT-proBNP) and galectin-3 were significantly correlated with ECV (rS = 0.34; P = 0.02; rS = 0.39; P = 0.006; rS = 0.43; P = 0.002, respectively). Galectin-3 and body mass index were found to be independent predictors of ECV (odds ratio [OR], 2.29 [1.07-4.91]; P = 0.03; OR, 0.81 [0.68-0.97]; P = 0.02, respectively).
Conclusions:
Galectin-3 was an independent predictor of interstitial fibrosis in HCM patients expressed as elevated ECV values. The other measured fibrosis-specific biomarkers were not useful in detecting interstitial fibrosis in HCM. In addition, there was a positive correlation between classical cardiac biomarkers and interstitial fibrosis in HCM patients.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure II: Pathophysiology
Myocarditis I: Introduction
Pathophysiology of Heart Failure

